Adult ADHD vs Anxiety: How Doctors Tell the Difference (And Why So Many Adults Have Both)
Quick answer: Adult ADHD and anxiety look similar on the surface — both cause restlessness, sleep problems, racing thoughts, and concentration difficulty — but they're clinically distinct conditions with different underlying mechanisms and different treatments. ADHD is a lifelong neurodevelopmental condition rooted in executive function deficits and present before age 12. Anxiety is driven by excessive worry, fear, and apprehension, often with physical symptoms like chest tightness or GI distress. The catch: roughly 50% of adults with ADHD also have an anxiety disorder, which is why proper diagnosis requires structured screening for both — not a 15-minute evaluation that picks one and prescribes. A correct diagnosis matters because stimulant medications can worsen untreated anxiety, and antidepressant medications alone won't address ADHD. Full clinical differentiation, symptom comparison, and treatment implications below.
Why This Question Matters So Much
Most adults reading this article are in one of three situations:
You suspect you have ADHD, but a previous provider told you it's "just anxiety" — and the anxiety treatment didn't help with the focus and follow-through problems
You've been treated for anxiety for years, but you still struggle with executive function — getting started, finishing tasks, managing time — in ways that don't feel anxiety-driven
You've been prescribed stimulants for ADHD, but they made your anxiety dramatically worse — and you're wondering whether the diagnosis was right in the first place
All three scenarios stem from the same underlying problem: the symptom overlap between ADHD and anxiety is so significant that a rushed clinical evaluation will frequently miss one diagnosis or confuse the two entirely. The consequence isn't just a missed diagnosis — it's years of ineffective treatment, worsening symptoms, and the corrosive belief that "nothing works for me."
The good news: when both conditions are properly diagnosed and treated, outcomes improve dramatically. The challenge is getting the diagnostic process right.
The Surface-Level Symptom Overlap
Here's why ADHD and anxiety get confused for each other so often. Both conditions can produce:
Difficulty concentrating
Restlessness, fidgeting, inability to sit still
Sleep problems — trouble falling asleep, racing thoughts at bedtime
Irritability and mood lability
Procrastination and avoidance of tasks
Forgetfulness and disorganization
Fatigue and exhaustion
Difficulty making decisions
Physical tension, headaches, GI distress (less common in pure ADHD)
A 15-minute clinical interview that focuses on these surface symptoms can plausibly land on either diagnosis. Which is why proper evaluation looks deeper — at why the symptoms are happening, when they started, and what triggers them.
The Underlying Differences
When you understand the underlying mechanisms of each condition, the symptom overlap stops being confusing and the differentiation becomes much clearer.
ADHD: A Neurodevelopmental Executive Function Disorder
ADHD is caused by differences in brain networks responsible for executive function — the cognitive processes that help you plan, prioritize, sustain attention, manage time, regulate impulses, and self-monitor. These differences are largely genetic, present from birth, and persist throughout life.
The hallmark features of ADHD are:
Executive function deficits — trouble starting tasks, breaking complex tasks into steps, prioritizing, switching between activities, and finishing what you've started
Attention dysregulation — the inability to deploy attention based on importance rather than interest. ADHD brains can hyperfocus intensely on novel or stimulating tasks while being utterly unable to attend to boring-but-important ones. Attention isn't deficient; it's misregulated.
Time blindness — chronic underestimation of how long tasks take, inability to feel the passage of time, missed deadlines despite genuine effort
Working memory limitations — losing track of conversations mid-sentence, forgetting why you walked into a room, dropping multi-step instructions
Impulsivity — interrupting, blurting, impulsive purchases or decisions, difficulty with delayed gratification
Emotional dysregulation — disproportionate emotional responses, rejection sensitivity, mood swings tied to immediate frustration
Reward system differences — difficulty sustaining motivation for activities without immediate reward; need for novelty and stimulation
Key diagnostic criteria (DSM-5-TR):
Symptoms present before age 12 (even if not formally diagnosed)
Symptoms present in 2+ settings (work and home, for example)
Significant impairment in occupational, academic, or social functioning
Not better explained by another condition
Anxiety Disorders: Excessive Worry, Fear, and Apprehension
Anxiety disorders are characterized by excessive, persistent worry and fear about future events, often with physical symptoms. Anxiety has a biological basis (involving the amygdala, hypothalamic-pituitary-adrenal axis, and serotonergic/GABAergic neurotransmission), but its onset, triggers, and content differ from ADHD's executive function deficits.
The hallmark features of generalized anxiety disorder (GAD) — the most common adult anxiety condition — are:
Excessive worry about multiple life domains (work, health, finances, relationships, minor everyday matters)
Apprehensive expectation — chronic sense that something bad is about to happen
Difficulty controlling the worry — once started, the worry spiral is hard to stop
Physical symptoms — muscle tension, fatigue, headaches, GI distress (nausea, IBS-like symptoms), chest tightness, shortness of breath, sweating
Sleep disturbance driven by worry — lying awake thinking about future events
Concentration difficulty caused by worry intrusion — mind keeps returning to anxious thoughts
Avoidance behaviors — staying away from situations that trigger anxiety
Anticipatory anxiety — getting anxious about future situations before they happen
Other anxiety disorders share features but with different focus:
Social anxiety disorder — fear of negative evaluation in social/performance situations
Panic disorder — recurrent panic attacks, intense fear of having more attacks
Specific phobias — fear of specific objects or situations
OCD (now classified separately but related) — intrusive thoughts and compulsive behaviors
Key diagnostic criteria (DSM-5-TR) for GAD:
Excessive anxiety and worry occurring more days than not for at least 6 months
Difficulty controlling the worry
Three or more associated symptoms: restlessness, fatigue, concentration difficulty, irritability, muscle tension, sleep disturbance
Significant impairment in functioning
Not better explained by another condition
Side-by-Side: How Doctors Actually Differentiate
| Feature | ADHD | Anxiety Disorder |
|---|---|---|
| Age of onset | Present before age 12 | Often adolescence or adulthood; can be tied to specific triggers |
| Symptom pattern | Chronic, lifelong, present across all settings | Often situational, tied to specific worries or triggers |
| Core cognitive issue | Executive function deficit (can't deploy attention as needed) | Attention captured by worry (focus too narrowed on threats) |
| Restlessness | Physical fidgeting, need to move, often unrelated to mood | Tied to feeling tense or "on edge"; often with muscle tension |
| Sleep problem type | "Brain won't turn off" — racing creative thoughts, jumping between topics | "Brain won't stop worrying" — repetitive thoughts about future events |
| Concentration problem | Mind drifts to new topics constantly; can hyperfocus on interesting things | Mind keeps returning to anxious thoughts; hard to focus even on interesting things |
| Time blindness | Chronic — losing track of time, missing deadlines | Less prominent; more anticipatory anxiety about deadlines |
| Physical symptoms | Less prominent | Prominent — chest tightness, GI distress, muscle tension, sweating |
| Response to deadlines | Often improves with deadline pressure (urgency boost) | Often worsens with deadlines (panic, freeze, avoid) |
| Effect of novelty | Hyperfocus on new/interesting things | Anxiety about novelty (especially social anxiety) |
| Mood regulation | Quick emotional reactions, rejection sensitivity, frustration tolerance issues | Pervasive worry-tone, sometimes depressed mood from chronic stress |
| Avoidance | Avoids boring tasks, struggles with task initiation | Avoids specific triggers (social situations, decisions, conflict) |
| Hyperfocus | Common — intense absorption in interesting tasks | Rare — anxious thoughts keep interrupting |
The Comorbidity Problem: When Both Conditions Are Present
Here's the part most rushed evaluations miss: roughly 50% of adults with ADHD also meet criteria for at least one anxiety disorder. Some studies put the lifetime co-occurrence rate as high as 60%. This isn't coincidence — there are clinical reasons the two conditions tend to cluster:
Genetic overlap — Twin studies suggest meaningful shared genetic risk for ADHD and anxiety disorders.
Cumulative consequences — Adults with ADHD who weren't diagnosed in childhood often develop chronic anxiety as a consequence of years of struggling. When you've spent decades missing deadlines, forgetting commitments, and getting negative feedback for things you couldn't control, worrying constantly that you'll mess up the next thing is a logical adaptation. The anxiety, in this case, is secondary to underlying ADHD.
Stress-amplification cycle — ADHD symptoms create stressors (financial strain from impulsive spending, relationship friction from time blindness, work problems from missed deadlines). These stressors generate anxiety. The anxiety further impairs concentration and executive function. The cycle reinforces itself.
Sleep deprivation — Both conditions impair sleep through different mechanisms. Chronic sleep deprivation worsens both conditions, blurring the diagnostic picture further.
The clinical implication: in a substantial number of adults presenting with apparent anxiety, ADHD is the underlying driver. In an even larger number presenting with apparent ADHD, anxiety is comorbid and needs separate treatment. Either condition treated alone — when both are present — produces incomplete results.
Why Misdiagnosis Happens So Often
A few specific reasons adults end up with the wrong diagnosis:
The 15-minute evaluation problem
Many telehealth platforms and even some in-person providers conduct ADHD or anxiety evaluations in 15-20 minutes. That's not enough time for the structured clinical interview, validated rating scale review, and comorbidity screening required for accurate diagnosis. A rushed evaluation defaults to whatever symptom the patient mentions first — often the one causing the most immediate distress, which is frequently anxiety (because anxiety produces acute physical discomfort while ADHD produces chronic functional impairment).
2. Symptom self-report ambiguity
When a patient says "I can't concentrate," that statement is equally consistent with ADHD attentional dysregulation and anxiety-driven worry intrusion. The differentiation requires probing why concentration is failing — is the patient's mind drifting to other interesting topics (ADHD pattern), or is it being captured by anxious thoughts about future events (anxiety pattern)? This kind of probing takes time and clinical skill.
3. Gender-based diagnostic bias
Women with ADHD are routinely diagnosed with anxiety or depression instead — partly because ADHD presents differently in women (more inattention, less hyperactivity) and partly because diagnostic criteria were historically built on observation of boys. A woman presenting with concentration difficulty, restlessness, and chronic worry may have:
Anxiety alone
ADHD with secondary anxiety from years of compensation
Both as comorbid conditions
Premenstrual or perimenopausal hormonal effects amplifying either
Some combination
Getting this right requires a detailed developmental history (was she struggling academically in middle school despite being smart?) and gender-aware diagnostic framing. Most rushed evaluations skip this step.
4. The "anxiety is the default" pattern
In primary care, when an adult complains of restlessness, concentration problems, and sleep disturbance, "anxiety" is the most common first-line working diagnosis. This isn't wrong — it's often correct. But when the patient doesn't respond well to anxiety treatment (SSRIs, therapy, anxiolytics), the next step should be reconsidering whether ADHD is also present or is the underlying driver. Many patients never reach that reconsideration step.
The Treatment Implications
The reason getting the diagnosis right matters so much: the medications for ADHD and anxiety can interact in ways that worsen the wrong-diagnosis patient.
Stimulant medications and anxiety
ADHD stimulants (Adderall, Vyvanse, Concerta, Ritalin) work by increasing dopamine and norepinephrine availability in the prefrontal cortex. This is exactly what an ADHD brain needs — but for a brain that's already running too hot from anxiety, additional adrenergic stimulation can:
Worsen physical anxiety symptoms (racing heart, sweating, jitteriness)
Trigger or amplify panic attacks
Increase rumination and worry intensity
Disrupt sleep further
This is why patients with comorbid ADHD and anxiety often report that stimulants "made my anxiety worse" — even though the stimulant did help the ADHD symptoms. The solution isn't usually to stop the stimulant; it's to treat the comorbid anxiety concurrently.
SSRIs and ADHD
SSRIs (Lexapro, Zoloft, Prozac, Celexa) are first-line for most anxiety disorders. They work — but they don't treat ADHD. A patient with undiagnosed comorbid ADHD who is treated with an SSRI alone may report:
"My anxiety is better but I still can't get anything done"
"I'm less panicky but I'm still always behind on everything"
"The medication helped with worry but my focus is still terrible"
Some SSRIs (particularly fluoxetine and paroxetine) can also mildly worsen attention and motivation in some patients, further complicating the picture.
Medications that may help both
Some medications work for both ADHD and anxiety to varying degrees:
Atomoxetine (Strattera) — selective norepinephrine reuptake inhibitor, FDA-approved for adult ADHD; can have modest anti-anxiety effects in some patients
Bupropion (Wellbutrin) — norepinephrine-dopamine reuptake inhibitor, off-label for ADHD; not typically helpful for anxiety and can occasionally worsen it
Guanfacine (Intuniv) — alpha-2 adrenergic agonist, FDA-approved for ADHD; can reduce some anxiety symptoms (particularly hyperarousal)
Clonidine — alpha-2 agonist, similar profile to guanfacine
The optimal approach for comorbid patients
When both conditions are present, current best practice is to treat both — but with a sequence and strategy that minimizes the medication-interaction problems:
Often start with the anxiety treatment (SSRI plus therapy) if anxiety is the more acutely impairing condition, then add ADHD treatment once the anxiety is stabilized
Sometimes start with a non-stimulant ADHD medication (atomoxetine, guanfacine) that has neutral or beneficial anxiety effects
Consider stimulants only after anxiety is well-controlled, with careful titration and monitoring
Therapy is critical — CBT for anxiety and behavioral strategies for ADHD work synergistically with medication
Treat sleep deprivation aggressively — both conditions worsen with poor sleep, and improving sleep alone often substantially improves both
This sequencing requires a physician who's diagnosed both conditions, understands both treatments, and is willing to spend time on a treatment plan that goes beyond "here's a prescription." It's not the standard 15-minute telehealth visit.
How Trinity Family Medicine Approaches This
Every Trinity Family Medicine ADHD evaluation includes structured anxiety screening, and every anxiety-focused visit includes screening for ADHD when symptoms suggest possible comorbidity. The diagnostic process uses:
Structured clinical interview against DSM-5-TR criteria for both ADHD and anxiety disorders
Validated rating scales — ASRS, CAARS, WURS for ADHD; GAD-7 and PHQ-9 for anxiety and depression screening
Developmental history — childhood symptoms (essential for ADHD diagnosis) and onset/trigger patterns (essential for anxiety differentiation)
Differentiation probing — asking specifically why concentration is failing, what triggers worry, what helps and what makes things worse
Treatment planning that addresses both conditions when both are present, with consideration of medication interactions and sequencing
Visits are conducted by Dr. Casey Dean, DO or Dr. Kathryn Kline, MD — both board-certified by the American Board of Family Medicine, both with stated expertise in mental health and chronic disease management. The same physician sees you for follow-ups, which matters because adjusting treatment for comorbid ADHD and anxiety often requires multiple visits and dose adjustments before the right combination is found.
Frequently Asked Questions
Can I have both ADHD and anxiety?
Yes — and it's common. Approximately 50% of adults with ADHD also meet criteria for at least one anxiety disorder. The comorbidity rate is high enough that any thorough ADHD evaluation should screen for anxiety, and vice versa. When both conditions are present, treating both produces substantially better outcomes than treating either alone.
How can I tell if my concentration problems are ADHD or anxiety?
The key question is why your concentration is failing. ADHD concentration problems feel like your mind drifts to whatever's more interesting in the moment — you can hyperfocus on engaging tasks but can't sustain attention on boring ones. Anxiety concentration problems feel like your mind keeps returning to worried thoughts about future events or current threats — you can't focus even on interesting things because anxiety keeps interrupting. Many adults experience both patterns, often at different times of day or in different situations.
My doctor says I have anxiety but the medication isn't working. Could it actually be ADHD?
Possibly — or it could be ADHD comorbid with anxiety, where the anxiety treatment helped the worry but didn't address the underlying executive function deficits. This is one of the most common scenarios we see. The next clinical step is a structured ADHD evaluation: detailed developmental history (were there signs of executive function problems before age 12?), validated rating scales (ASRS, CAARS, WURS), and comorbidity reassessment. If both conditions are present, treatment should address both — usually by adding ADHD-specific medication (often a non-stimulant first) and behavioral strategies to your existing anxiety regimen.
Can ADHD cause anxiety?
Yes, in two senses. First, untreated ADHD frequently leads to secondary anxiety — the chronic worry that develops from years of struggling with executive function failure (missing deadlines, forgetting commitments, financial chaos from impulsive decisions). This kind of anxiety often improves substantially once ADHD is properly treated. Second, ADHD and anxiety share genetic risk factors, so they co-occur more often than chance would predict. In some patients the anxiety is primary; in others it's secondary to ADHD; in many it's both.
Will ADHD medication make my anxiety worse?
It depends on the medication and the type of anxiety. Stimulant medications (Adderall, Vyvanse, Concerta) can worsen anxiety in patients whose anxiety is poorly controlled — by increasing physical symptoms (racing heart, jitteriness) and intensifying rumination. This is why current best practice for patients with comorbid ADHD and anxiety is often to stabilize the anxiety first (with SSRIs and/or therapy), then add ADHD treatment. Non-stimulant ADHD medications (atomoxetine, guanfacine, clonidine) generally don't worsen anxiety and may help some anxiety symptoms.
Should I see a psychiatrist or a family physician for ADHD and anxiety?
Either can be appropriate. Board-certified family medicine physicians regularly diagnose and manage both ADHD and anxiety, particularly when the cases are straightforward. Psychiatry referral is appropriate for complex cases involving multiple medications, treatment resistance, severe symptoms, or co-occurring conditions like bipolar disorder. Many adults are well-served by their family physician for both conditions, with psychiatry consultation when needed. The most important factor is choosing a provider who takes the time to do a structured evaluation — not the specific specialty.
How long does it take to figure out the right treatment for comorbid ADHD and anxiety?
Usually 2–4 months. The initial evaluation establishes the diagnoses. The first treatment trial (often anxiety medication first if anxiety is more acutely impairing) is given 4–6 weeks to take effect. Then a second medication may be added (often non-stimulant or stimulant for ADHD). Doses are adjusted over 1–3 months based on response. Most patients reach a stable, effective regimen within 4 months of starting treatment. Patients who switch providers frequently or skip follow-up visits often never reach this stable point.
What's the GAD-7 and why should I take one before my visit?
The GAD-7 (Generalized Anxiety Disorder 7-item scale) is a validated 7-question screening tool for anxiety. It's brief (under 2 minutes), well-validated, and gives the physician an objective baseline measure to track over time. Trinity Family Medicine includes the GAD-7 and PHQ-9 (for depression) in our pre-visit intake whenever ADHD evaluation is requested, because comorbidity screening is part of standard care for ADHD. A baseline score also lets us measure whether treatment is working — a follow-up GAD-7 in 6 weeks shows objectively whether your anxiety symptoms have improved.
Can therapy help with both ADHD and anxiety?
Yes — different types of therapy for each. Cognitive behavioral therapy (CBT) for anxiety has strong evidence and is often combined with SSRI medication. Behavioral therapy and coaching for ADHD — focused on executive function strategies, time management, and habit formation — has growing evidence and works well alongside ADHD medication. Some therapists specialize in both. Therapy is particularly valuable for the comorbid case because medication alone often doesn't address the years of compensatory patterns that adults with undiagnosed ADHD have built up.
Does insurance cover comorbid ADHD and anxiety treatment?
Most major insurance plans cover both ADHD and anxiety treatment. Texas HB 1052 (effective January 1, 2026) requires Texas insurance plans to cover telehealth at parity with in-person care. Trinity Family Medicine operates on a cash-pay model ($119.99 ADHD initial evaluation, $74.99 follow-up; sick visit pricing $49.99 for ongoing care) and provides HSA/FSA superbills for reimbursement. Medication prescriptions are sent to your local Texas pharmacy where pharmacy benefit insurance applies.
What if I'm wrong about which condition I have?
That's exactly what a proper evaluation is designed to figure out. Patients often come in convinced they have ADHD, anxiety, depression, or some combination, and the evaluation sometimes confirms that, sometimes refines it, and sometimes finds something different (sleep disorders, thyroid disease, vitamin deficiencies, and perimenopausal hormonal effects can all mimic ADHD or anxiety symptoms). The diagnostic process is collaborative — the physician asks structured questions and uses validated tools, you provide your history and observations, and together you arrive at the most accurate clinical picture.
The Bottom Line
ADHD and anxiety look similar on the surface but are distinct clinical conditions requiring different treatments. The differentiation matters because the wrong diagnosis leads to ineffective treatment, and stimulant medications can worsen poorly controlled anxiety. Roughly half of adults with ADHD have comorbid anxiety, which means a thorough evaluation should always screen for both.
The single most important factor in getting this right is the quality and depth of the evaluation. A 15-minute visit defaulting to whichever symptom is mentioned first will routinely miss the diagnosis. A structured clinical interview using DSM-5-TR criteria, validated rating scales (ASRS, CAARS, WURS for ADHD; GAD-7 for anxiety), and comorbidity screening — followed by a treatment plan that accounts for both conditions when both are present — produces dramatically better outcomes.
If you've been treated for one condition and the treatment isn't working as expected, the next step isn't a different dose of the same medication. It's a reconsideration of whether the other condition is also present.
Trinity Family Medicine evaluates adult ADHD using structured DSM-5-TR clinical interviews and validated rating scales, with anxiety, depression, sleep, and substance use comorbidity screening built into every visit. Initial ADHD evaluation $119.99. Same Texas-licensed physician for all follow-ups. Book a visit across 251 Texas counties via telehealth.
Sources
American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR), 2022
Kessler, R.C. et al., "The Prevalence and Correlates of Adult ADHD in the United States: Results from the National Comorbidity Survey Replication," American Journal of Psychiatry
Sobanski, E. et al., "Psychiatric Comorbidity and Functional Impairment in a Clinically Referred Sample of Adults with Attention-Deficit/Hyperactivity Disorder (ADHD)," European Archives of Psychiatry and Clinical Neuroscience
Katzman, M.A. et al., "Adult ADHD and Comorbid Disorders: Clinical Implications of a Dimensional Approach," BMC Psychiatry
World Health Organization, Adult ADHD Self-Report Scale (ASRS-v1.1)
Spitzer, R.L. et al., "A Brief Measure for Assessing Generalized Anxiety Disorder: The GAD-7," Archives of Internal Medicine
Kroenke, K. et al., "The PHQ-9: Validity of a Brief Depression Severity Measure," Journal of General Internal Medicine
National Institute of Mental Health, "Attention-Deficit/Hyperactivity Disorder in Adults"
National Institute of Mental Health, "Anxiety Disorders"
American Academy of Family Physicians, clinical guidance on adult ADHD and anxiety disorders
Medical Disclaimer: The information provided in this article is for educational and informational purposes only and is not intended as medical advice, diagnosis, or treatment. Always seek the advice of your physician or another qualified healthcare provider with any questions you may have regarding a medical condition.
About the Author
Board-Certified Family Medicine Physician (ABFM)
Dr. Kathryn Kline is a board-certified family medicine physician and co-founder of Trinity Family Medicine. She is dedicated to mental and emotional wellness, women's health, and chronic disease management, serving patients across Texas via secure telehealth.
Credentials & Memberships:
- Doctor of Medicine (MD) — University of Cincinnati Medical Center
- Family Medicine Residency — Waco Family Medicine (Nationally Ranked)
- Board Certified — American Board of Family Medicine (ABFM)
- Texas Medical Board License: #T3117
- Specialty: Mental Health, Women's Health, Chronic Disease Management
Medical Review Date: June 2026, by Dr. Casey Dean, DO, Board-Certified Family Medicine Physician (ABFM)
Standard Texas Telehealth Medical Disclaimer
Medical Disclaimer: The information provided in this article is for educational and informational purposes only and is not intended as medical advice, diagnosis, or treatment. Always seek the advice of your physician or another qualified healthcare provider with any questions you may have regarding a medical condition.
Emergency Notice: If you are experiencing a medical emergency, please call 911 or go to the nearest emergency room immediately. A virtual consultation is not a substitute for emergency medical care.
Texas Patient Notice: Use of this website or the information contained herein does not establish a doctor-patient relationship. A formal relationship is only established after a synchronous video consultation with a Texas-licensed provider and the completion of all required intake documentation.
Ready to Feel Better?
Connect with a Texas-licensed physician today — no waiting rooms, no hassle.
Book Your ConsultationRelated Articles
Anxiety Disorder: When Worry Becomes a Medical Condition — and What Your Doctor Can Do About It
Nearly 1 in 5 U.S. adults lives with an anxiety disorder, and most never get treated. A board-certified Texas physician explains when worry crosses into a medical condition and what evidence-based treatment looks like.
Read moreDepression: The Most Common Condition Your Doctor Can Treat — and the One Most Often Left Untreated
Nearly 1 in 5 American adults has depression, yet most go untreated. A board-certified Texas physician explains how depression is diagnosed and treated in primary care — and why telehealth is closing the gap.
Read moreADHD Telehealth Texas: How to Get Diagnosed and Treated Online Without the Wait
ADHD affects an estimated 9% of Texans, and the majority of adults living with it have never been diagnosed. Learn how telehealth provides a legitimate pathway to life-changing care — fully compliant with Texas Medical Board and DEA regulations.
Read more